Keywords: Myocardium, Safety, Youth-onset T2D, CMR, 4D flow MRI
Motivation: Increasing prevalence of youth-onset type 2 diabetes (T2D) is a global concern and characterized by a higher risk for hyperuricemia, a strong risk factor for cardiovascular disease (CVD).
Goal(s): Studies have shown that serum uric acid (SUA) lowering in the general population may confer cardiovascular protection, but there have been no studies on its effectiveness in young adults with T2D.
Approach: Here, we hypothesized aggressive SUA lowering using single intravenous infusion dose of the uricase, pegloticase, will attenuate cardiac magnetic resonance imaging (CMR) markers of CVD in young adults with T2D.
Results: Unexpectedly, we documented impaired CMR-based global longitudinal strain after pegloticase infusion.
Impact: Our study demonstrates the impacts of a drug therapy to reduce serum uric acid in youth-onset T2D and its impact on cardiovascular function using CMR. A comprehensive examination of the cardiovascular effects of the therapy is required for youth-onset T2D.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords